Vir Biotechnology (VIR) Enterprise Value (2018 - 2026)
Vir Biotechnology (VIR) posted Enterprise Value of -$205.2 million for Q1 2026, up 13.89% sequentially from -$238.3 million in Q4 2025, and up 66.12% YoY from -$123.5 million in Q1 2025.
Vir Biotechnology (VIR) Enterprise Value (2018 - 2026) Analysis & Trends
Vir Biotechnology has reported Enterprise Value for 9 years, with the latest figure at -$205.2 million in Q1 2026.
- Quarterly Enterprise Value rose 66.12% year-over-year to -$205.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$205.2 million (up 66.12% YoY) and the FY2025 annual result came in at -$238.3 million, up 68.95% from the prior year.
- Enterprise Value rose to -$205.2 million in Q1 2026 per VIR's latest filing, from -$238.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$205.2 million in Q1 2026 and troughed at -$2.3 billion in Q3 2022.
- A 5-year average of -$1.0 billion and a median of -$998.5 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value slumped 2269.96% in 2022, then jumped 83.57% in 2024.
- Over 5 years, Enterprise Value stood at -$1.5 billion in 2022, then increased by 1.41% to -$1.5 billion in 2023, then surged by 49.26% to -$767.4 million in 2024, then jumped by 68.95% to -$238.3 million in 2025, then increased by 13.89% to -$205.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$205.2 million, -$238.3 million, and -$330.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn | -528.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -528.59 Mn |
| Mar 31, 2026 | -205.18 Mn |
| Dec 31, 2025 | -238.26 Mn |
| Sep 30, 2025 | -329.97 Mn |
| Jun 30, 2025 | -218.37 Mn |
| Mar 31, 2025 | -605.52 Mn |
| Dec 31, 2024 | -767.44 Mn |
| Sep 30, 2024 | -908.96 Mn |
| Jun 30, 2024 | -301.23 Mn |
| Mar 31, 2024 | -998.46 Mn |
| Dec 31, 2023 | -1.51 Bn |
| Sep 30, 2023 | -1.25 Bn |
| Jun 30, 2023 | -1.83 Bn |
| Mar 31, 2023 | -1.42 Bn |
| Dec 31, 2022 | -1.53 Bn |
| Sep 30, 2022 | -2.32 Bn |
| Jun 30, 2022 | -2.16 Bn |
| Mar 31, 2022 | -1.21 Bn |
| Dec 31, 2021 | -565.00 Mn |
| Sep 30, 2021 | -770.08 Mn |